Orient Laboratories Private Limited
About Orient Laboratories Private Limited
Data last updated:
Orient Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 23 September 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH1994PTC081425.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rashmikant Mansukhlal Shah and Kevin Rajendrakumar Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹75,000. For the same year it recorded a net loss of ₹16,000 (net margin -21.3%) and EBITDA of -₹15,000 (EBITDA margin -20%).
As per MCA filings, the company has satisfied charges of ₹7.2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Orient Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressO – 201 Floor – 2 Plot – 575 The Orient Seth Bhagwan Road Off. J Jamshed Road Five Garden Ma, Tunga, Mumbai, Maharashtra, India – 400019
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Orient Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Orient Laboratories Private Limited
FY 2025 filings availableOrient Laboratories Private Limited reported revenue of ₹75,000 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹15,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹16,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -20% | ||||
| Net Profit Margin | -21.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Orient Laboratories Private Limited, buy the company report.
Board of directors of Orient Laboratories Private Limited
Orient Laboratories has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rashmikant Mansukhlal Shah Also directs: Orient Health Services LLP, Orient Healthcare Private Limited, Orient Realtors Private Limited and 5 more | Director | 27 Jan 2021 | 5 Years 8 Months | Current |
| Kevin Rajendrakumar Shah Also directs: Orient Healthcare Private Limited, Orient Premises Private Limited, Orient Autocare Private Limited and 5 more | Additional Director | 24 Mar 2023 | 3 Years 6 Months | Current |
Peer comparison
Orient Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sushmitha Medical Centre Pvt. Ltd. | ₹90,000 (FY 2024) | Vijayawada, Andhra Pradesh, India | ||||
| Qnova Healthcare Private Limited | ₹87,660 (FY 2025) | -95.0% | Bengaluru, Karnataka, India | |||
| Siwach Radiology Services Private Limited | ₹85,504 (FY 2024) | 39.0% | New Delhi, Delhi, India | |||
| O2 Pathlabs Private Limited | ₹80,000 (FY 2025) | -98.0% | New Delhi, Delhi, India | |||
| Ojasinfinity Pharma Private Limited | ₹76,933 (FY 2025) | Bangalore, Karnataka, India | ||||
| Orient Laboratories Private Limitedthis company | ₹75,000 (FY 2025) | -₹16,000 | -21.3% | Mumbai, Maharashtra, India | ||
| Health Care Services Private Limited | ₹72,990 (FY 2025) | -97.0% | Kolkata, West Bengal, India | |||
| Pulse Healthcare Private Limited | ₹71,463 (FY 2022) | -20.0% | Bangalore, Karnataka, India | |||
| Causeway Healthcare Private Limited | ₹69,279 (FY 2025) | 15.0% | Pune, Maharashtra, India | |||
| Chennai Medicare Center Private Limited | ₹69,174 (FY 2023) | Chennai, Tamil Nadu, India | ||||
| My Lab Medisolutions Private Limited | ₹68,550 (FY 2023) | -27.0% | Aurangabad, Maharashtra, India |
To see the full peer comparison of Orient Laboratories Private Limited, buy the company report.
Auditor
Orient Laboratories Private Limited is audited by TRIPATHI AND COMPANY for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TRIPATHI AND COMPANY | FY 2020 | 132804W |
Shareholding
The shareholding of Orient Laboratories Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Orient Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Aug 2018 | 100204721 | Others | ₹5 Cr | Satisfied | |
| 07 Sep 2015 | 10590114 | Kotak Mahindra Bank Limited | ₹2.2 Cr | Satisfied |
To see the full charge records of Orient Laboratories Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Orient Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orient Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Orient Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Orient Laboratories Private Limited has 6 board changes on record since 2015: 2 appointments and 4 cessations. The latest: Indra Meghraj Jain ceased to be Director on 24 Mar 2023.
1 earlier event is in the company report.
Frequently asked questions
Orient Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 23 September 1994 (32+ years old) and is registered under CIN U24110MH1994PTC081425.
Orient Laboratories has 2 current directors:
- Rashmikant Mansukhlal Shah - Director
- Kevin Rajendrakumar Shah - Additional Director
The latest financial statements of Orient Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Orient Laboratories is U24110MH1994PTC081425. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orient Laboratories was incorporated on 23 September 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Orient Laboratories by revenue are Sushmitha Medical Centre Pvt. Ltd, Qnova Healthcare Private Limited, Siwach Radiology Services Private Limited, O2 Pathlabs Private Limited, Ojasinfinity Pharma Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Indra Meghraj Jain ceased to be Director on 24 Mar 2023. Kankubai Sohanlal Jain ceased to be Director on 24 Mar 2023. Kevin Rajendrakumar Shah was appointed as Additional Director on 24 Mar 2023. Orient Laboratories has 6 board changes on record in total.
The registered office of Orient Laboratories is at O – 201 Floor – 2 Plot – 575 The Orient Seth Bhagwan Road Off. J Jamshed Road Five Garden Ma, Tunga, Mumbai, Maharashtra, India – 400019.
Orient Laboratories operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
Orient Laboratories has no open charges and satisfied charges of ₹7.2 Cr as per latest MCA filings.
The compliance status of Orient Laboratories is compliant as of 27 September 2026. The company is actively filing with the Registrar of Companies.